The hypothesis that immunotherapy combined with chemotherapy is synergistic is widely accepted, mainly because cytotoxic drugs can release immunogenic tumor antigens by killing tumor cells and induce upregulation of PD-L1 expression [39], which provides a rationale for PD-1 or PD-L1 therapy. Here, PDCD1 is linked to neoplasm.